Literature DB >> 21784342

Volumetric and visual rating of magnetic resonance imaging scans in the diagnosis of amnestic mild cognitive impairment and Alzheimer's disease.

Qian Shen1, David A Loewenstein, Elizabeth Potter, Weizhao Zhao, Jason Appel, Maria T Greig, Ashok Raj, Amarilis Acevedo, Elizabeth Schofield, Warren Barker, Yougui Wu, Huntington Potter, Ranjan Duara.   

Abstract

BACKGROUND: In the diagnosis of Alzheimer's disease (AD), structural magnetic resonance imaging (MRI) scans have been used primarily to exclude non-Alzheimer's causes of dementia. However, the pattern and the extent of medial temporal atrophy on structural MRI scans, which correlate strongly with the pathological severity of AD, can be used to support the diagnosis of a degenerative dementia, especially AD, even in its early predementia stage.
METHODS: Elderly subjects (n = 224) were diagnosed with either no cognitive impairment (NCI), amnestic mild cognitive impairment (aMCI), or AD. Hippocampal and hemispheric gray matter volumes were measured on structural MRI scans, and a new visual rating system was used to score the severity of medial temporal atrophy (VRS-MTA) of the hippocampus (HPC), entorhinal cortex, and perirhinal cortex on a coronal image intersecting the mammillary bodies.
RESULTS: Although both VRS-MTA scores and HPC volumes distinguished between subjects with NCI, aMCI, and AD, subjects with aMCI and NCI could be better distinguished using right VRS-MTA scores, in comparison with right HPC volumes. VRS-MTA scores were more highly correlated with episodic memory and Clinical Dementia Rating scores. A combination of left sided VRS-MTA scores and left sided hippocampal volume was the most predictive measure of diagnostic classification.
CONCLUSION: VRS-MTA is a clinically convenient method or distinguishing aMCI or AD from NCI. As compared with volumetric measures, it provides better discriminatory power and correlates more strongly with memory and functional scores.
Copyright © 2011 The Alzheimer's Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21784342      PMCID: PMC3145968          DOI: 10.1016/j.jalz.2010.07.002

Source DB:  PubMed          Journal:  Alzheimers Dement        ISSN: 1552-5260            Impact factor:   21.566


  36 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  Visual assessment of medial temporal atrophy on MR films in Alzheimer's disease: comparison with volumetry.

Authors:  Lorena Bresciani; Roberta Rossi; Cristina Testa; Cristina Geroldi; Samantha Galluzzi; Mikko P Laakso; Alberto Beltramello; Hilkka Soininen; Giovanni B Frisoni
Journal:  Aging Clin Exp Res       Date:  2005-02       Impact factor: 3.636

3.  An MRI-based method for measuring volume, thickness and surface area of entorhinal, perirhinal, and posterior parahippocampal cortex.

Authors:  Eric Feczko; Jean C Augustinack; Bruce Fischl; Bradford C Dickerson
Journal:  Neurobiol Aging       Date:  2007-09-11       Impact factor: 4.673

4.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors:  C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

5.  Functional deficits in patients with mild cognitive impairment: prediction of AD.

Authors:  M H Tabert; S M Albert; L Borukhova-Milov; Y Camacho; G Pelton; X Liu; Y Stern; D P Devanand
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

6.  Medial temporal structures relate to memory impairment in Alzheimer's disease: an MRI volumetric study.

Authors:  E Mori; Y Yoneda; H Yamashita; N Hirono; M Ikeda; A Yamadori
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-08       Impact factor: 10.154

7.  Reliability and validity of an algorithm for the diagnosis of normal cognition, mild cognitive impairment, and dementia: implications for multicenter research studies.

Authors:  Ranjan Duara; David A Loewenstein; Maria Greig; Amarilis Acevedo; Elizabeth Potter; Jason Appel; Ashok Raj; John Schinka; Elizabeth Schofield; Warren Barker; Yougui Wu; Huntington Potter
Journal:  Am J Geriatr Psychiatry       Date:  2010-04       Impact factor: 4.105

8.  Fully-automated quantification of regional brain volumes for improved detection of focal atrophy in Alzheimer disease.

Authors:  J B Brewer; S Magda; C Airriess; M E Smith
Journal:  AJNR Am J Neuroradiol       Date:  2008-12-26       Impact factor: 3.825

9.  Damage to the perirhinal cortex exacerbates memory impairment following lesions to the hippocampal formation.

Authors:  S Zola-Morgan; L R Squire; R P Clower; N L Rempel
Journal:  J Neurosci       Date:  1993-01       Impact factor: 6.167

10.  Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study.

Authors:  L W de Jong; K van der Hiele; I M Veer; J J Houwing; R G J Westendorp; E L E M Bollen; P W de Bruin; H A M Middelkoop; M A van Buchem; J van der Grond
Journal:  Brain       Date:  2008-11-20       Impact factor: 13.501

View more
  36 in total

1.  The nuances of cognition and depression in older adults: the need for a comprehensive assessment.

Authors:  Patrick J Brown; Joel R Sneed; Bret R Rutherford; D P Devanand; Steven P Roose
Journal:  Int J Geriatr Psychiatry       Date:  2013-10-03       Impact factor: 3.485

2.  Grey-matter volume as a potential feature for the classification of Alzheimer's disease and mild cognitive impairment: an exploratory study.

Authors:  Yane Guo; Zengqiang Zhang; Bo Zhou; Pan Wang; Hongxiang Yao; Minshao Yuan; Ningyu An; Haitao Dai; Luning Wang; Xi Zhang; Yong Liu
Journal:  Neurosci Bull       Date:  2014-04-23       Impact factor: 5.203

3.  Recovery from Proactive Semantic Interference in Mild Cognitive Impairment and Normal Aging: Relationship to Atrophy in Brain Regions Vulnerable to Alzheimer's Disease.

Authors:  David A Loewenstein; Rosie E Curiel; Clinton Wright; Xiaoyan Sun; Noam Alperin; Elzabeth Crocco; Sara J Czaja; Arlene Raffo; Ailyn Penate; Jose Melo; Kimberly Capp; Monica Gamez; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

4.  Recovery from Proactive Semantic Interference and MRI Volume: A Replication and Extension Study.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Monica Rosselli; Russell Bauer; Maria Grieg-Custo; Ailyn Penate; Chunfei Li; Gabriel Lizagarra; Todd Golde; Malek Adjouadi; Ranjan Duara
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

5.  Relationship between Cognitive Performance and Measures of Neurodegeneration among Hispanic and White Non-Hispanic Individuals with Normal Cognition, Mild Cognitive Impairment, and Dementia.

Authors:  Shanna L Burke; Miriam J Rodriguez; Warren Barker; Maria T Greig-Custo; Monica Rosselli; David A Loewenstein; Ranjan Duara
Journal:  J Int Neuropsychol Soc       Date:  2017-09-18       Impact factor: 2.892

6.  A novel cognitive assessment paradigm to detect Pre-mild cognitive impairment (PreMCI) and the relationship to biological markers of Alzheimer's disease.

Authors:  Elizabeth A Crocco; David A Loewenstein; Rosie E Curiel; Noam Alperin; Sara J Czaja; Philip D Harvey; Xiaoyan Sun; Joshua Lenchus; Arlene Raffo; Ailyn Peñate; Jose Melo; Lee Sang; Rosemery Valdivia; Karen Cardenas
Journal:  J Psychiatr Res       Date:  2017-08-24       Impact factor: 4.791

7.  Multimodality Imaging of Dementia: Clinical Importance and Role of Integrated Anatomic and Molecular Imaging.

Authors:  Kunal P Patel; David T Wymer; Vinay K Bhatia; Ranjan Duara; Chetan D Rajadhyaksha
Journal:  Radiographics       Date:  2020 Jan-Feb       Impact factor: 5.333

8.  Clinical and radiological characteristics of early versus late mild cognitive impairment in patients with comorbid depressive disorder.

Authors:  Jeffrey N Motter; Gregory H Pelton; Kristina D'Antonio; Sara N Rushia; Monique A Pimontel; Jeffrey R Petrella; Ernst Garcon; Michaela W Ciovacco; Joel R Sneed; P Murali Doraiswamy; Davangere P Devanand
Journal:  Int J Geriatr Psychiatry       Date:  2018-07-23       Impact factor: 3.485

9.  Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.

Authors:  David A Loewenstein; Rosie E Curiel; Steven DeKosky; Russell M Bauer; Monica Rosselli; Salvador M Guinjoan; Malek Adjouadi; Ailyn Peñate; William W Barker; Sindy Goenaga; Todd Golde; Maria T Greig-Custo; Kevin S Hanson; Chunfei Li; Gabriel Lizarraga; Michael Marsiske; Ranjan Duara
Journal:  Neurology       Date:  2018-08-03       Impact factor: 9.910

10.  Biomarkers for the clinical evaluation of the cognitively impaired elderly: amyloid is not enough.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Imaging Med       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.